🇺🇸 FDA
Pipeline program

Gallium-68 NODAGA-JR11

FirstAHFujian8

Phase 1 small_molecule active

Quick answer

Gallium-68 NODAGA-JR11 for Neuroendocrine Tumors is a Phase 1 program (small_molecule) at The First People's Hospital of Lianyungang with 1 ClinicalTrials.gov record(s).

Program details

Company
The First People's Hospital of Lianyungang
Indication
Neuroendocrine Tumors
Phase
Phase 1
Modality
small_molecule
Status
active

Clinical trials